Addex Therapeutics Ltd (ADXN) News
Track canonical SquawkNews coverage tagged to ADXN, Addex Therapeutics Ltd. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 5 indexed stories across 4 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Addex Therapeutics to Report 2026 Half-Year Financial Results and Host Conference Call on September 28, 2026
Geneva, Switzerland, September 24, 2026 - Addex Therapeutics (SIX and NASDAQ:ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurologi
EARNINGS | Sep 24, 2026, 05:00 AM UTC
M
Premarket gainers list led by RFAI, RFAIR and HOWL
TradeXchange Newsdesk lists the top ten premarket percentage gainers, led by RFAI at +411.70%, RFAIR at +125.00% and HOWL at +76.57%, with no catalyst supplied.
EQUITY | Aug 21, 2026, 09:17 AM UTC
M
ADXN Reports Q1 2026 Results
Addex Therapeutics reports Q1 2026 results with operating loss of 0.5 million Swiss francs and cash on hand of 0.9 million
EARNINGS | Jun 25, 2026, 03:00 PM UTC
H
Earnings Scheduled For June 25, 2026
Companies Reporting Before The Bell • TD Synnex (NYSE: SNX ) is projected to report quarterly earnings at $4.10 per share on revenue of $16.79 billion. • Yiren Digital (NYSE: YRD ) is estimated to report earnings for its
EARNINGS | Jun 25, 2026, 11:11 AM UTC
M
ADXN, FRVO, POWW Report Earnings
ADXN, FRVO, and POWW are reporting earnings before the market opens on Monday, June 22.
EARNINGS | Jun 21, 2026, 12:36 PM UTC